Interestingly, promoter methylation for p16 has been associated with tobacco use (Belinsky et al., 1998; Belinsky et al., 2002; Yanagawa et al., 2002), the greatest risk factor for developing lung cancer. This evidence concerns the gene CDKN2A and lung carcinoma.